US$65 Billion Opportunity in the Global Peptide Therapeutics Market: Clinical & Patent Insight on 197 Marketed Peptides

News provided by

Jan 31, 2020, 06:45 ET

DUBLIN, Jan. 31, 2020 /PRNewswire/ -- The "Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026" report has been added to ResearchAndMarkets.com's offering.

Global Peptide Drug Market Is Projected To Surpass US$ 60 Billion By 2026 Driven By Strong Clinical Pipeline & Favorable Commercialization Parameters.

The peptide drug market is flourishing and several peptide-based therapeutics have been commercialized. With enhanced technologies, the prospects of the peptide drugs are getting influential day by day and new peptides are being discovered to be developed as peptide drug. Peptide therapeutics is completely different from the traditional way and may open a new window for finding completely new peptide drugs. Also, bioinformatics and systematic biological approaches help in searching for potential peptide drug candidates based on the knowledge and data.

The future potential of expanding peptide therapeutics market is contributed towards the characteristics like safety, targeted drug delivery and high specificity. Especially for illnesses requiring prolonged therapy, peptides have a competitive advantage over conventional small molecule drugs. Due to their extremely high specificity for their intended target, in combination with the fact that they are extra cellularly active, much lower amounts can be formulated.

The Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026 report gives comprehensive insight on clinical and non-clinical parameters involved in the development of the global peptide drug market. As per report findings, peptides have emerged as one of the important classes of therapeutic molecules which have been developed by varied pharmaceutical and biotech companies in order to attain a targeted drug discovery for several ailments. Currently, there are more than 800 peptide drugs in clinical pipeline and 197 peptide-based drugs commercially available in the market.

The Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026 report highlights:

Companies Mentioned

Global Peptide Therapeutics Market Opportunity: US$ 65 Billion
Cancer Peptide Therapeutics Market Opportunity: US$ 22 Billion
Insight Peptide Drugs in Clinical Trials: 807 Peptides Drugs
Clinical & Patent Insight on 197 Marketed Peptides
Peptide Clinical Pipeline Is Dominated by Cyclic Peptides: 46 Peptides
Peptides Clinical Trials Insight by Phase, Indication & Company
Future Peptide Therapeutics Market Outlook

Amgen
Amylin Pharmaceuticals
Apitope Technology
BioPartners
BiondVax Pharmaceuticals Ltd
Boehringer Ingelheim
Circassia
Corden Pharma (Peptisyntha)
Eli Lily
Galena Biopharmaceuticals
GlaxoSmithKline
Hyperion Therapeutics
ImmunoCellular Therapeutics
Ipsen
Lonza
Merck
NovoNordisk
Par Pharmaceuticals
PeptiDream
Roche
Sanofi
Tarix Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/r/xdbii1

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets